Effects of Pea Proteins on Muscle Damage and Recovery

Inclusion Criteria: * Provide voluntary signed and dated informed consent. * Be in good health as determined by medical history and routine blood chemistries. * Age between the ages of 18 and 55 (inclusive). * Body Mass Index of 18.5-29.9 (inclusive). * Subject agrees to maintain existing dietary patterns throughout the study period apart from ingesting the provided treatment beverage. * Subject is willing and able to comply with the study and supplement protocol. * Subject agrees to abstain from alcohol, coffee, and caffeinated beverages 24 hours prior to testing on all study visits. * Subject agrees to abstain from strenuous exercise 72 hours prior to testing on all study visits. * Body weight of at least 120 pounds. * Normotensive (seated, resting systolic blood pressure \<140 mm Hg and diastolic blood pressure \< 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5 minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility. * Normal seated, resting heart rate (\<90 per minute). * Willing to duplicate their previous 24-hour and fast for 8 hours prior each study visit. Exclusion Criteria: * Individuals who have been diagnosed with liver, renal, cardiovascular, or other metabolic disease. * Use of any dietary supplements which may confound the study or its endpoints, including creatine, BCAA, HMB, betaine, beta-alanine, etc. * Use of any prescription medications (particularly antibiotics and/or anti-inflammatories), or probiotics within the past 2 months which may confound the study or its endpoints. * Alcohol consumption (more than 2 standard alcoholic drinks per day or more than 10 drinks per week) or drug abuse or dependence. * Smokers. * Clinically significant abnormal laboratory results at screening. * Known sensitivity to any ingredient in the test formulations as listed in the Nutrition Facts label. * Individuals who are cognitively impaired and/or who are unable to give informed consent. * Individuals with diabetes, asthma, chronic inflammatory conditions (e.g., rheumatoid arthritis, colitis, IBS/IBD, gout or fibromyalgia, Crohn's disease, ulcerative colitis, Lupus, HIV/AIDS, etc.). * Other known gastrointestinal or metabolic diseases that might impact nutrient absorption or metabolism, e.g., short bowel syndrome, diarrheal illnesses, history of colon resection, gastro paresis, Inborn-Errors-of-Metabolism (such as PKU). * Individuals with excessive caffeine intake (600mg/day). * Subjects who take medication which may adversely affect the measured outcomes (i.e., testosterone or other anabolic steroids, corticosteroids or testosterone replacement therapy (ingestion, injection, or transdermal), diuretics, etc.) * History of malignancy in the previous 5 years except for non-melanoma skin cancer (basal cell cancer or squamous cell cancer of the skin). * Prior gastrointestinal bypass surgery (i.e., Lapband, etc.). * Women * Currently participating in another research study with an investigational product or have been in another research study in the past 30 days. * Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject.